Christian Hopfer
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 38 | 2025 | 1094 | 3.520 |
Why?
| | Marijuana Abuse | 21 | 2024 | 211 | 3.380 |
Why?
| | Cannabis | 13 | 2025 | 509 | 2.960 |
Why?
| | Conduct Disorder | 16 | 2023 | 160 | 2.060 |
Why?
| | Marijuana Use | 9 | 2025 | 213 | 1.740 |
Why?
| | Adolescent Behavior | 16 | 2020 | 501 | 1.400 |
Why?
| | Alcoholism | 20 | 2025 | 817 | 1.370 |
Why?
| | Alcohol Drinking | 16 | 2024 | 826 | 1.350 |
Why?
| | Marijuana Smoking | 9 | 2022 | 250 | 1.320 |
Why?
| | Antisocial Personality Disorder | 16 | 2025 | 121 | 1.240 |
Why?
| | Social Environment | 10 | 2014 | 254 | 1.120 |
Why?
| | Tobacco Use Disorder | 11 | 2020 | 218 | 1.110 |
Why?
| | Polymorphism, Single Nucleotide | 22 | 2025 | 2145 | 1.060 |
Why?
| | Adolescent | 93 | 2025 | 22428 | 1.000 |
Why?
| | Siblings | 13 | 2025 | 195 | 0.970 |
Why?
| | Genetic Predisposition to Disease | 17 | 2025 | 2363 | 0.950 |
Why?
| | Medical Marijuana | 4 | 2025 | 123 | 0.940 |
Why?
| | Twins | 10 | 2025 | 156 | 0.860 |
Why?
| | Smoking | 17 | 2019 | 1472 | 0.810 |
Why?
| | Genome-Wide Association Study | 15 | 2025 | 1406 | 0.800 |
Why?
| | Risk-Taking | 7 | 2019 | 328 | 0.680 |
Why?
| | Legislation, Drug | 4 | 2023 | 73 | 0.660 |
Why?
| | Analgesics, Opioid | 7 | 2020 | 1143 | 0.660 |
Why?
| | Young Adult | 39 | 2025 | 14105 | 0.640 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 232 | 0.630 |
Why?
| | Mental Disorders | 9 | 2025 | 1168 | 0.620 |
Why?
| | Humans | 129 | 2025 | 144759 | 0.620 |
Why?
| | Problem Behavior | 2 | 2018 | 102 | 0.610 |
Why?
| | Female | 98 | 2025 | 78271 | 0.610 |
Why?
| | Colorado | 23 | 2022 | 4564 | 0.610 |
Why?
| | Male | 96 | 2025 | 72315 | 0.610 |
Why?
| | Dronabinol | 2 | 2020 | 247 | 0.600 |
Why?
| | Diseases in Twins | 4 | 2014 | 115 | 0.590 |
Why?
| | Cannabinol | 1 | 2019 | 2 | 0.590 |
Why?
| | Opioid-Related Disorders | 5 | 2021 | 600 | 0.580 |
Why?
| | Homeless Youth | 3 | 2008 | 22 | 0.560 |
Why?
| | Hallucinogens | 1 | 2020 | 108 | 0.550 |
Why?
| | Adult | 61 | 2025 | 40449 | 0.540 |
Why?
| | Criminals | 1 | 2018 | 33 | 0.540 |
Why?
| | Longitudinal Studies | 26 | 2025 | 2947 | 0.540 |
Why?
| | Heroin Dependence | 3 | 2003 | 33 | 0.530 |
Why?
| | Substance Abuse, Intravenous | 3 | 2016 | 128 | 0.520 |
Why?
| | Sexual Behavior | 5 | 2019 | 491 | 0.520 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 147 | 0.510 |
Why?
| | Prescription Drug Misuse | 1 | 2017 | 51 | 0.510 |
Why?
| | Cigarette Smoking | 1 | 2018 | 99 | 0.510 |
Why?
| | Receptors, Nicotinic | 7 | 2016 | 321 | 0.500 |
Why?
| | Genetic Linkage | 3 | 2008 | 273 | 0.490 |
Why?
| | Prescription Drug Diversion | 1 | 2016 | 13 | 0.470 |
Why?
| | Prevalence | 11 | 2022 | 2834 | 0.460 |
Why?
| | Crohn Disease | 1 | 2019 | 260 | 0.450 |
Why?
| | Genotype | 15 | 2019 | 1833 | 0.450 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 6 | 2025 | 428 | 0.430 |
Why?
| | Motivation | 2 | 2018 | 610 | 0.420 |
Why?
| | Accidents, Traffic | 2 | 2018 | 190 | 0.410 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 365 | 0.390 |
Why?
| | Receptors, Dopamine D2 | 4 | 2007 | 93 | 0.390 |
Why?
| | Body Mass Index | 3 | 2018 | 2438 | 0.380 |
Why?
| | Family Health | 1 | 2014 | 191 | 0.380 |
Why?
| | Polymorphism, Genetic | 4 | 2016 | 612 | 0.370 |
Why?
| | Genetic Variation | 5 | 2022 | 983 | 0.360 |
Why?
| | Phenotype | 15 | 2025 | 3162 | 0.340 |
Why?
| | Comorbidity | 9 | 2016 | 1658 | 0.310 |
Why?
| | Urban Population | 2 | 2012 | 491 | 0.300 |
Why?
| | Surveys and Questionnaires | 13 | 2019 | 6048 | 0.300 |
Why?
| | Sleep | 3 | 2025 | 901 | 0.300 |
Why?
| | Child Abuse | 6 | 2021 | 551 | 0.300 |
Why?
| | Biological Specimen Banks | 4 | 2019 | 102 | 0.300 |
Why?
| | Nurses, Community Health | 2 | 2019 | 38 | 0.290 |
Why?
| | Substance Abuse Detection | 2 | 2020 | 106 | 0.290 |
Why?
| | Multifactorial Inheritance | 4 | 2025 | 202 | 0.290 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2019 | 186 | 0.290 |
Why?
| | Impulsive Behavior | 4 | 2017 | 146 | 0.290 |
Why?
| | Prenatal Care | 3 | 2019 | 307 | 0.290 |
Why?
| | Prospective Studies | 9 | 2020 | 7990 | 0.290 |
Why?
| | United States | 18 | 2025 | 15966 | 0.290 |
Why?
| | Criminal Behavior | 2 | 2018 | 4 | 0.290 |
Why?
| | United Kingdom | 3 | 2019 | 338 | 0.280 |
Why?
| | Haplotypes | 5 | 2009 | 490 | 0.280 |
Why?
| | Juvenile Delinquency | 5 | 2018 | 95 | 0.270 |
Why?
| | Adolescent Development | 2 | 2019 | 72 | 0.270 |
Why?
| | House Calls | 2 | 2019 | 154 | 0.270 |
Why?
| | Genetic Association Studies | 4 | 2021 | 372 | 0.260 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2006 | 36 | 0.250 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 14 | 0.250 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2006 | 43 | 0.250 |
Why?
| | Sex Factors | 10 | 2017 | 2112 | 0.250 |
Why?
| | Cognition | 4 | 2020 | 1266 | 0.250 |
Why?
| | Mental Health | 2 | 2025 | 790 | 0.250 |
Why?
| | Health Surveys | 5 | 2012 | 518 | 0.250 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5868 | 0.250 |
Why?
| | Case-Control Studies | 10 | 2019 | 3604 | 0.250 |
Why?
| | Multigene Family | 3 | 2013 | 204 | 0.240 |
Why?
| | Homosexuality | 1 | 2006 | 17 | 0.240 |
Why?
| | Analgesics | 2 | 2020 | 228 | 0.240 |
Why?
| | Home Care Services | 2 | 2019 | 280 | 0.240 |
Why?
| | Drug Prescriptions | 2 | 2018 | 284 | 0.240 |
Why?
| | Bisexuality | 1 | 2006 | 39 | 0.230 |
Why?
| | Receptors, Dopamine D1 | 1 | 2006 | 35 | 0.230 |
Why?
| | Mothers | 3 | 2019 | 775 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 2 | 2020 | 576 | 0.230 |
Why?
| | Tobacco Use | 2 | 2024 | 61 | 0.230 |
Why?
| | Aggression | 4 | 2022 | 179 | 0.220 |
Why?
| | Research Subjects | 2 | 2015 | 41 | 0.220 |
Why?
| | Environment | 5 | 2012 | 305 | 0.220 |
Why?
| | Personality Disorders | 1 | 2025 | 79 | 0.220 |
Why?
| | Registries | 1 | 2014 | 2385 | 0.220 |
Why?
| | Linkage Disequilibrium | 7 | 2021 | 246 | 0.210 |
Why?
| | Substance Abuse Treatment Centers | 3 | 2012 | 49 | 0.210 |
Why?
| | Child Behavior Disorders | 3 | 2011 | 118 | 0.210 |
Why?
| | Genome | 1 | 2006 | 306 | 0.210 |
Why?
| | Personality | 1 | 2025 | 132 | 0.210 |
Why?
| | Child | 24 | 2025 | 22633 | 0.200 |
Why?
| | Twins, Monozygotic | 5 | 2010 | 134 | 0.200 |
Why?
| | Genomics | 3 | 2020 | 834 | 0.200 |
Why?
| | Age of Onset | 5 | 2018 | 551 | 0.200 |
Why?
| | Internationality | 2 | 2022 | 156 | 0.200 |
Why?
| | Risk Factors | 13 | 2025 | 10779 | 0.200 |
Why?
| | Interview, Psychological | 4 | 2013 | 94 | 0.200 |
Why?
| | Genetic Loci | 3 | 2022 | 261 | 0.200 |
Why?
| | Gene Frequency | 6 | 2016 | 481 | 0.200 |
Why?
| | Obesity | 1 | 2017 | 3077 | 0.200 |
Why?
| | Alleles | 8 | 2018 | 879 | 0.200 |
Why?
| | Adoption | 1 | 2003 | 25 | 0.190 |
Why?
| | Heroin | 1 | 2003 | 29 | 0.190 |
Why?
| | Narcotics | 1 | 2003 | 55 | 0.190 |
Why?
| | Models, Genetic | 6 | 2010 | 536 | 0.190 |
Why?
| | Nerve Tissue Proteins | 5 | 2013 | 592 | 0.190 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 62 | 0.180 |
Why?
| | Incidence | 4 | 2018 | 2879 | 0.170 |
Why?
| | Age Factors | 6 | 2014 | 3333 | 0.170 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 301 | 0.170 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 56 | 0.170 |
Why?
| | Public Health | 1 | 2006 | 566 | 0.160 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 45 | 0.160 |
Why?
| | Middle Aged | 15 | 2025 | 35875 | 0.160 |
Why?
| | Monoamine Oxidase | 2 | 2013 | 25 | 0.160 |
Why?
| | Health Risk Behaviors | 1 | 2019 | 15 | 0.150 |
Why?
| | Twins, Dizygotic | 4 | 2010 | 109 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 52 | 0.150 |
Why?
| | Nausea | 1 | 2020 | 111 | 0.150 |
Why?
| | Autistic Disorder | 1 | 2022 | 211 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 88 | 0.150 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 194 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.150 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 8 | 0.140 |
Why?
| | Expressed Emotion | 1 | 2018 | 15 | 0.140 |
Why?
| | Calcium-Transporting ATPases | 1 | 2018 | 33 | 0.140 |
Why?
| | Mortality, Premature | 1 | 2018 | 14 | 0.140 |
Why?
| | Depression | 3 | 2022 | 1558 | 0.140 |
Why?
| | Multimodal Imaging | 1 | 2019 | 124 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 454 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 109 | 0.140 |
Why?
| | HIV Infections | 1 | 2013 | 3154 | 0.130 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2019 | 123 | 0.130 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 162 | 0.130 |
Why?
| | Urine | 1 | 2017 | 62 | 0.130 |
Why?
| | Pregnancy | 5 | 2022 | 7190 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 173 | 0.130 |
Why?
| | Cannabinoids | 2 | 2017 | 182 | 0.130 |
Why?
| | Bioethics | 1 | 2017 | 25 | 0.130 |
Why?
| | Unsafe Sex | 2 | 2016 | 61 | 0.130 |
Why?
| | Receptors, Opioid, mu | 2 | 2015 | 68 | 0.130 |
Why?
| | Biomedical Research | 2 | 2014 | 710 | 0.130 |
Why?
| | Gene-Environment Interaction | 2 | 2020 | 180 | 0.120 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1134 | 0.120 |
Why?
| | Counseling | 1 | 2020 | 408 | 0.120 |
Why?
| | Administration, Oral | 1 | 2019 | 847 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2020 | 6429 | 0.120 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 37 | 0.120 |
Why?
| | Brain Mapping | 1 | 2019 | 536 | 0.120 |
Why?
| | Suicide | 2 | 2021 | 720 | 0.120 |
Why?
| | Mental Competency | 1 | 2015 | 26 | 0.120 |
Why?
| | Drug Storage | 1 | 2016 | 53 | 0.120 |
Why?
| | Brain | 2 | 2019 | 2933 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 225 | 0.120 |
Why?
| | Self Report | 2 | 2018 | 872 | 0.110 |
Why?
| | Patient Admission | 2 | 2012 | 218 | 0.110 |
Why?
| | Lipids | 1 | 2020 | 710 | 0.110 |
Why?
| | Surgical Procedures, Operative | 1 | 2018 | 270 | 0.110 |
Why?
| | Exploratory Behavior | 2 | 2013 | 86 | 0.110 |
Why?
| | Life Change Events | 1 | 2016 | 147 | 0.110 |
Why?
| | Drug Overdose | 2 | 2018 | 370 | 0.110 |
Why?
| | Neuroimaging | 1 | 2017 | 289 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 780 | 0.110 |
Why?
| | Automobile Driving | 1 | 2016 | 155 | 0.110 |
Why?
| | Conflict of Interest | 1 | 2014 | 52 | 0.100 |
Why?
| | Interviews as Topic | 3 | 2007 | 901 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2018 | 704 | 0.100 |
Why?
| | Medicine | 1 | 2016 | 125 | 0.100 |
Why?
| | Informed Consent | 1 | 2015 | 198 | 0.100 |
Why?
| | Netherlands | 1 | 2014 | 82 | 0.100 |
Why?
| | Regression Analysis | 3 | 2019 | 1003 | 0.100 |
Why?
| | Cohort Studies | 6 | 2021 | 5960 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2019 | 592 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 3 | 2019 | 1356 | 0.100 |
Why?
| | Genetic Testing | 1 | 2016 | 478 | 0.100 |
Why?
| | Aged | 6 | 2018 | 25913 | 0.100 |
Why?
| | Time Factors | 3 | 2019 | 7173 | 0.100 |
Why?
| | Proteomics | 1 | 2020 | 1195 | 0.100 |
Why?
| | Temperament | 1 | 2013 | 38 | 0.100 |
Why?
| | Condoms | 1 | 2013 | 101 | 0.100 |
Why?
| | Receptors, GABA-A | 1 | 2014 | 138 | 0.090 |
Why?
| | Emotions | 2 | 2021 | 578 | 0.090 |
Why?
| | Patient Safety | 1 | 2016 | 347 | 0.090 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 20 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2925 | 0.090 |
Why?
| | Family Conflict | 1 | 2012 | 43 | 0.090 |
Why?
| | Sexual Partners | 1 | 2013 | 192 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1326 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1539 | 0.090 |
Why?
| | Family Relations | 1 | 2012 | 88 | 0.090 |
Why?
| | Educational Status | 1 | 2013 | 467 | 0.090 |
Why?
| | Pentachlorophenol | 1 | 1990 | 21 | 0.080 |
Why?
| | Logistic Models | 4 | 2019 | 2117 | 0.080 |
Why?
| | Ethanol | 2 | 2012 | 627 | 0.080 |
Why?
| | Psychometrics | 3 | 2009 | 734 | 0.080 |
Why?
| | Dizziness | 1 | 2010 | 101 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 582 | 0.070 |
Why?
| | Sample Size | 2 | 2022 | 123 | 0.070 |
Why?
| | Genetic Markers | 2 | 2007 | 331 | 0.070 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 39 | 0.070 |
Why?
| | Models, Statistical | 2 | 2010 | 681 | 0.070 |
Why?
| | Taq Polymerase | 2 | 2006 | 8 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4271 | 0.070 |
Why?
| | Hospitalization | 1 | 2019 | 2433 | 0.070 |
Why?
| | Child Abuse, Sexual | 1 | 2009 | 81 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3863 | 0.070 |
Why?
| | Suicidal Ideation | 3 | 2021 | 577 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1733 | 0.070 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 10 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 13 | 0.070 |
Why?
| | Methylphenidate | 2 | 2004 | 49 | 0.060 |
Why?
| | Stress, Psychological | 1 | 2016 | 1152 | 0.060 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 64 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2008 | 284 | 0.060 |
Why?
| | Risk | 2 | 2020 | 911 | 0.060 |
Why?
| | Retrospective Studies | 8 | 2021 | 17066 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 2310 | 0.060 |
Why?
| | Schizophrenia | 2 | 2022 | 446 | 0.060 |
Why?
| | Family | 4 | 2016 | 679 | 0.060 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 152 | 0.060 |
Why?
| | Child of Impaired Parents | 1 | 2006 | 38 | 0.060 |
Why?
| | Quality of Life | 1 | 2019 | 3185 | 0.060 |
Why?
| | Cheek | 1 | 2006 | 16 | 0.060 |
Why?
| | Fathers | 1 | 2006 | 51 | 0.060 |
Why?
| | Lysergic Acid Diethylamide | 1 | 2006 | 3 | 0.060 |
Why?
| | Social Facilitation | 1 | 2006 | 9 | 0.060 |
Why?
| | Sodium Oxybate | 1 | 2006 | 5 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 11 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 157 | 0.060 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 120 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 252 | 0.060 |
Why?
| | Genetics, Population | 1 | 2007 | 214 | 0.060 |
Why?
| | Central Nervous System Stimulants | 2 | 2004 | 185 | 0.060 |
Why?
| | Poverty | 2 | 2019 | 529 | 0.060 |
Why?
| | Religion | 1 | 2006 | 65 | 0.060 |
Why?
| | Confidence Intervals | 2 | 2006 | 333 | 0.060 |
Why?
| | Parenting | 1 | 2009 | 318 | 0.050 |
Why?
| | Methamphetamine | 1 | 2006 | 70 | 0.050 |
Why?
| | Parents | 2 | 2004 | 1403 | 0.050 |
Why?
| | Beta Rhythm | 1 | 2004 | 33 | 0.050 |
Why?
| | Ketamine | 1 | 2006 | 132 | 0.050 |
Why?
| | Universities | 1 | 2007 | 452 | 0.050 |
Why?
| | Suicide, Attempted | 1 | 2008 | 422 | 0.050 |
Why?
| | Pain Management | 2 | 2019 | 405 | 0.050 |
Why?
| | Marriage | 1 | 2004 | 122 | 0.050 |
Why?
| | Data Interpretation, Statistical | 3 | 2010 | 372 | 0.050 |
Why?
| | Drug Tolerance | 1 | 2003 | 100 | 0.050 |
Why?
| | Genome, Human | 2 | 2020 | 422 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2019 | 11679 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 154 | 0.050 |
Why?
| | Infant | 3 | 2021 | 10034 | 0.040 |
Why?
| | Europe | 1 | 2022 | 412 | 0.040 |
Why?
| | Models, Psychological | 2 | 2016 | 299 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1985 | 0.040 |
Why?
| | Loneliness | 1 | 2022 | 60 | 0.040 |
Why?
| | Personality Assessment | 2 | 2013 | 79 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2115 | 0.040 |
Why?
| | Calibration | 1 | 2021 | 151 | 0.040 |
Why?
| | Methadone | 1 | 2002 | 121 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2003 | 496 | 0.040 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1325 | 0.040 |
Why?
| | Electroencephalography | 1 | 2003 | 532 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5408 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1054 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 433 | 0.040 |
Why?
| | Minnesota | 1 | 2020 | 169 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2022 | 280 | 0.040 |
Why?
| | Dangerous Behavior | 1 | 2018 | 17 | 0.040 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 75 | 0.040 |
Why?
| | Drug Utilization Review | 1 | 2019 | 61 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2019 | 109 | 0.040 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2019 | 151 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 61 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 154 | 0.030 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 26 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 427 | 0.030 |
Why?
| | Factor Analysis, Statistical | 2 | 2010 | 293 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2019 | 125 | 0.030 |
Why?
| | Preoperative Period | 1 | 2018 | 149 | 0.030 |
Why?
| | Limit of Detection | 1 | 2017 | 97 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 98 | 0.030 |
Why?
| | Gene Expression | 2 | 2016 | 1490 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 354 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 461 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2010 | 541 | 0.030 |
Why?
| | Chromosome Mapping | 2 | 2008 | 510 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11787 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2016 | 35 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 476 | 0.030 |
Why?
| | California | 1 | 2017 | 475 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 1045 | 0.030 |
Why?
| | Nicotine | 2 | 2010 | 331 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 471 | 0.030 |
Why?
| | Quality Control | 1 | 2016 | 163 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 375 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 594 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 145 | 0.030 |
Why?
| | Reward | 1 | 2017 | 247 | 0.030 |
Why?
| | Psychology, Adolescent | 1 | 2015 | 63 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2003 | 1560 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 315 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 178 | 0.030 |
Why?
| | Violence | 1 | 2018 | 281 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 143 | 0.030 |
Why?
| | Thoracic Surgical Procedures | 1 | 2016 | 94 | 0.030 |
Why?
| | Sexually Transmitted Diseases | 1 | 2016 | 166 | 0.030 |
Why?
| | Demography | 1 | 2015 | 288 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 1109 | 0.030 |
Why?
| | Disclosure | 1 | 2014 | 85 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 224 | 0.030 |
Why?
| | Aging | 1 | 2004 | 1966 | 0.030 |
Why?
| | Arsenites | 1 | 1993 | 6 | 0.030 |
Why?
| | Arsenic Poisoning | 1 | 1993 | 7 | 0.020 |
Why?
| | Cotinine | 1 | 2013 | 79 | 0.020 |
Why?
| | Arsenicals | 1 | 1993 | 28 | 0.020 |
Why?
| | Chelating Agents | 1 | 1993 | 71 | 0.020 |
Why?
| | Risk Assessment | 2 | 2015 | 3671 | 0.020 |
Why?
| | Gluconeogenesis | 1 | 1993 | 83 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2016 | 547 | 0.020 |
Why?
| | Kidney Tubules | 1 | 1993 | 117 | 0.020 |
Why?
| | Child Behavior | 2 | 2005 | 236 | 0.020 |
Why?
| | Psychological Theory | 1 | 2013 | 93 | 0.020 |
Why?
| | Probability | 1 | 2013 | 310 | 0.020 |
Why?
| | Privacy | 1 | 2012 | 41 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1486 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2016 | 737 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 514 | 0.020 |
Why?
| | Students | 1 | 2017 | 663 | 0.020 |
Why?
| | Antidotes | 1 | 1993 | 145 | 0.020 |
Why?
| | Pleasure | 1 | 2010 | 18 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2847 | 0.020 |
Why?
| | Software | 1 | 2016 | 690 | 0.020 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3409 | 0.020 |
Why?
| | Sensation | 1 | 2010 | 55 | 0.020 |
Why?
| | Chromatography, Gas | 1 | 1990 | 32 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1185 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 321 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4282 | 0.020 |
Why?
| | Exercise | 1 | 2021 | 2201 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1166 | 0.020 |
Why?
| | Negotiating | 1 | 2009 | 34 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2012 | 465 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 983 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 132 | 0.020 |
Why?
| | Molecular Structure | 1 | 1990 | 499 | 0.020 |
Why?
| | Epistasis, Genetic | 1 | 2009 | 66 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 134 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2007 | 88 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 983 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 1075 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2009 | 1306 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2009 | 270 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 758 | 0.010 |
Why?
| | Rats | 2 | 1993 | 5597 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 854 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 797 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2004 | 160 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 8265 | 0.010 |
Why?
| | Schools | 1 | 2006 | 453 | 0.010 |
Why?
| | Research Design | 1 | 2009 | 1135 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2004 | 529 | 0.010 |
Why?
| | Housing | 1 | 2004 | 144 | 0.010 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 59 | 0.010 |
Why?
| | Family Characteristics | 1 | 2004 | 197 | 0.010 |
Why?
| | Attention | 1 | 2004 | 457 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1496 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1837 | 0.010 |
Why?
| | DNA | 1 | 2007 | 1463 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2003 | 538 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 2029 | 0.010 |
Why?
| | Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| | Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| | Dimercaprol | 1 | 1993 | 6 | 0.010 |
Why?
| | Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1993 | 397 | 0.010 |
Why?
| | Arsenic | 1 | 1993 | 66 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1993 | 194 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1993 | 1047 | 0.010 |
Why?
| | Animals | 2 | 1993 | 38058 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1993 | 2527 | 0.000 |
Why?
| | Mice | 1 | 1993 | 18339 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|